RBM47 and cancer: Bioinformatics analysis and research results prompted that RBM47 was reduced in ccRCC cancer tissues in TCGA-KRIC, ICGC, GEO, CPTAC, and clinical samples, its low expression indicated poor prognosis in ccRCC.